Irene Zacheo

Meldola, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Erratum: Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 27, 2026

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2026

Unveiling Cryptic BCR-ABL1 Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid Malignancies.

Unveiling Cryptic BCR-ABL1 Rearrangements: Diagnostic Challenges and Clinical Impact in Myeloid Malignancies.

Journal: International journal of molecular sciences
Published: July 31, 2025

Novel insights and therapeutic approaches in secondary AML.

Novel insights and therapeutic approaches in secondary AML.

Journal: Frontiers in oncology
Published: March 13, 2024

Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia.

Venetoclax and hypomethylating agents in octogenarians and nonagenarians with acute myeloid leukemia.

Journal: Blood neoplasia
Published: November 13, 2023

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease.

Journal: Haematologica
Published: September 25, 2023

Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.

Uncovering the expression of circPVT1 in the extracellular vesicles of acute myeloid leukemia patients.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 18, 2023

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.

Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL.

Journal: Blood
Published: December 12, 2018

A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.

A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison.

Journal: Clinical lymphoma, myeloma & leukemia
Published: October 30, 2018

(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.

(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.

Journal: Annals of hematology
Published: May 29, 2018

Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.

Rituximab in a risk-adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: British journal of haematology
Published: July 25, 2017

Safety and comfort of domestic bortezomib injection in real-life experience.

Safety and comfort of domestic bortezomib injection in real-life experience.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 24, 2017
Showing 1-12 of 26

Last Updated: 09/26/2026